new glp 1 agonist novo nordisk oral has received European Commission approval for Wegovy® pill, making it the first GLP-1 receptor authorised for weight management across the European Union. The EU decision marks Novo Nordisk is slashing GLP-1

Tesamorelins trans-3-hexenoic acid modification at the N-terminus protects against DPP-IV cleavage, extending its effective half-life compared to native GHRH

This renders it applicable in the state of upper respiratory infection, chronic bronchitis and pulmonary diseases where it aids in the betterment of breathing and removal of harmful debris in the lungs

Personalized Care Through Zappy Zappy offers personalized wellness solutions designed to support your health and vitality, featuring compounded medications sourced from trusted, licensed pharmacies

Newsholme P, Cruzat VF, Keane KN, Carlessi R, de Bittencourt PI Jr

Before stopping GLP-1 medications, consult with your healthcare provider

Patients should contact their GP or diabetes team if they experience any unusual symptoms, particularly abdominal pain, skin changes, joint pain, or signs of infection